Eagle Pharmaceuticals Inc Free Cash Flow Generation Index
Eagle Pharmaceuticals Inc free cash flow generation index. Eagle Pharmaceuticals Inc (EGRX) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of $37.55 Million represents 1% of operating cash flow ($37.56 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Eagle Pharmaceuticals Inc (2016–2022)
Free cash flow generation index of Eagle Pharmaceuticals Inc from 2016 to 2022. Historical FCF Generation Index trend for Eagle Pharmaceuticals Inc across 7 annual periods. See Eagle Pharmaceuticals Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Eagle Pharmaceuticals Inc Free Cash Flow Generation Index by Year (2016–2022)
Eagle Pharmaceuticals Inc free cash flow generation index by year from 2016 to 2022. Year-by-year Free Cash Flow Generation Index for Eagle Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Eagle Pharmaceuticals Inc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.00x | $30.80 Million | $30.80 Million | $178.00K | ▲ +1.2% |
| 2021 | 0.99x | $27.90 Million | $28.22 Million | $323.00K | ▲ +0.4% |
| 2020 | 0.98x | $48.75 Million | $49.50 Million | $747.00K | ▼ -0.1% |
| 2019 | 0.99x | $55.21 Million | $55.99 Million | $777.00K | ▼ -1.1% |
| 2018 | 1.00x | $52.25 Million | $52.38 Million | $133.00K | ▲ +9.4% |
| 2017 | 0.91x | $53.73 Million | $58.92 Million | $5.19 Million | ▲ +49.2% |
| 2016 | 0.61x | $32.52 Million | $53.21 Million | $20.69 Million | — |